Bristol Myers Squibb (BMS), a leading global biopharmaceutical company, is headquartered in the United Arab Emirates (AE) and operates extensively across North America, Europe, and Asia. Founded in 1887, BMS has a rich history marked by significant milestones in drug development and innovation. Specialising in oncology, immunology, cardiovascular diseases, and fibrosis, Bristol Myers Squibb is renowned for its unique portfolio of therapies, including groundbreaking treatments like Opdivo and Eliquis. These products are distinguished by their advanced mechanisms of action and proven efficacy, positioning BMS as a frontrunner in the pharmaceutical industry. With a commitment to research and development, Bristol Myers Squibb has achieved notable recognition, consistently ranking among the top biopharmaceutical companies globally. Its dedication to improving patient outcomes underscores its pivotal role in transforming healthcare.
We don't have data for Bristol Myers Squibb, but we can show you information about their parent organization instead.
View parent company